Vision & Mission

Crusade aims to successfully explore, innovate and imaginatively apply our acquired knowledge of herpes simplex virus biotechnology for human benefit.

Key Strategic priorities

In achieving our vision and mission we focus on the following strategic priorities:

• Apply oncolytic and enhanced oncolytic HSV to the treatment of human cancer, including the research and development of efficient delivery technologies (systemic and immune evasion development)
• Investigate and apply the properties of HSV as an efficient gene delivery vehicle for the many gene based disease treatments molecular medicine is identifying.
• Provide differentiated contract research services to the biotechnology industry, based on our unique experience and knowledge in the regulatory and operational aspects of clinical trials of biological agents